# Keller et al. (2024) Two-Day CPET Study - Key Findings Summary

## Citation
Keller, B.A., Receno, C.N., Franconi, C.J., et al. (2024). Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations. *Journal of Translational Medicine*, 22(1), 627.

**DOI:** 10.1186/s12967-024-05410-5
**PMID:** 38965566
**PMCID:** PMC11229500

## Download Links

| Source | URL |
|--------|-----|
| PMC (Full Text + PDF) | https://pmc.ncbi.nlm.nih.gov/articles/PMC11229500/ |
| Journal (BioMed Central) | https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05410-5 |
| PDF Direct | https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-024-05410-5.pdf |
| PubMed | https://pubmed.ncbi.nlm.nih.gov/38965566/ |

**License:** Open Access (CC BY 4.0)

## Study Design

- **Total enrolled:** 171 individuals (81 controls, 90 ME/CFS)
- **Final analysis:** 155 participants (71 controls, 84 ME/CFS)
- **Diagnostic criteria:** Canadian Consensus Criteria
- **Matched subset:** 55 pairs matched by sex, age, and baseline VO₂peak
- **Protocol:** Two maximal CPETs on cycle ergometer separated by 24 hours
- **Funding:** NIH U54 cooperative agreement, Cornell CRC for ME/CFS

## Key Findings: Day 1 vs Day 2 Changes

### ME/CFS Participants (Significant Declines Day 2 vs Day 1)
| Parameter | Day 2 Change | p-value |
|-----------|-------------|---------|
| VO₂peak | -5.3% ↓ | p < 0.01 |
| Work | -5.5% ↓ | p < 0.01 |
| Ventilation (V̇E) | -7.8% ↓ | p < 0.01 |
| Heart Rate | -2.6% ↓ | p < 0.05 |
| O₂ pulse | -4.0% ↓ | p < 0.05 |
| Anaerobic threshold VO₂ | -6.7% ↓ | p < 0.05 |

### Control Participants
**No significant changes** in any parameter from Day 1 to Day 2

## Clinical Implications

### Objective PEM Documentation
- First large-scale study (n=84) demonstrating objective failure to recover within 24 hours
- ME/CFS participants met maximal effort criteria on both days, yet couldn't reproduce Day 1 performance
- Provides quantifiable evidence of post-exertional malaise

### Impairment Severity Worsening
- **Day 1:** 14% classified as severely impaired (based on anaerobic threshold)
- **Day 2:** 27% classified as severely impaired (nearly doubled)
- Cannot be explained by deconditioning or lack of effort

### Matched Pair Analysis
- When ME/CFS and controls were matched for identical baseline aerobic capacity (VO₂peak)
- ME/CFS participants **still** showed abnormal Day 2 responses
- **Conclusion:** Fitness level does not predispose to exertion intolerance in ME/CFS

## Pathophysiological Mechanisms Implicated

### Autonomic Nervous System Dysregulation
- Primary driver of impaired exercise response
- Affects:
  - Blood flow distribution during exercise
  - Oxygen delivery to working muscles
  - Cardiac output regulation
  - Ventilatory control

### Disrupted Cardiopulmonary Integration
- **Cardiac:** Chronotropic incompetence (inadequate heart rate response)
- **Pulmonary:** Reduced ventilatory efficiency
- **Metabolic:** Impaired oxygen extraction and utilization

### Energy Metabolism Failure
- Reduced oxygen consumption indicates mitochondrial dysfunction downstream effects
- O₂ pulse decline suggests reduced stroke volume or oxygen extraction
- Anaerobic threshold shift shows earlier reliance on anaerobic metabolism

## Complementarity with Walitt 2024 NIH Study

### Walitt Study Showed:
- Single-day CPET: reduced peak VO₂, chronotropic incompetence
- Brain dysfunction: temporoparietal junction hypoactivation during effort
- CSF metabolomics: catecholamine and tryptophan pathway alterations
- Immune: increased naïve B-cells, decreased switched memory B-cells

### Keller Study Adds:
- **Temporal dimension:** How exercise Day 1 impairs Day 2 performance (PEM mechanism)
- **Reproducibility:** Validated finding across 84 patients at multiple sites
- **Clinical utility:** Quantifiable functional impairment for disability documentation
- **Recovery kinetics:** 24-hour period insufficient for physiological restoration

### Integrated Picture:
**Walitt:** "What's broken" → Central catecholamine dysregulation, immune exhaustion, metabolic alterations
**Keller:** "What happens when you use the broken system" → Functional collapse with measurable cardiopulmonary and metabolic consequences

## Treatment Implications

### Activity Pacing
- Heart rate monitoring: Stay below anaerobic threshold (AT - 15 bpm recommended by Workwell Foundation)
- Avoid triggering Day 2 performance decline
- Recovery periods must exceed 24 hours for exertional activities

### Targeting Autonomic Dysfunction
- Therapies addressing autonomic regulation may be more effective than fitness training
- GET (graded exercise therapy) contraindicated - worsens physiological function
- Focus on symptom-triggered activity restriction

### Disability Documentation
- 2-day CPET provides objective, reproducible evidence for disability claims
- Shows measurable functional impairment distinct from deconditioning
- Quantifies severity progression with exertion

## Integration Points in Your Manuscript

### Chapter 6 (Energy Metabolism)
- Add subsection on "Exercise-Induced Metabolic Failure"
- Document VO₂peak and anaerobic threshold declines Day 2
- Link to mitochondrial dysfunction consequences

### Chapter 8 (Neurological)
- Connect to Walitt's TPJ hypoactivation findings
- Autonomic dysregulation affecting cardiopulmonary control
- Central vs peripheral fatigue distinction

### Chapter 10 (Cardiovascular)
- Chronotropic incompetence detailed findings
- O₂ pulse decline (stroke volume or extraction issues)
- Recovery kinetics

### Chapter 15 (Treatment/Medications)
- Pacing protocols using heart rate thresholds
- Contraindication for GET/exercise-based therapies
- Autonomic-targeting treatments

### Chapter 16 (Supplements/Nutraceuticals)
- Potential targets: mitochondrial support, oxygen utilization enhancers
- Evidence gaps for improving 2-day CPET outcomes

### Chapter 18 (Emerging Therapies)
- Interventions specifically targeting autonomic dysfunction
- Recovery acceleration strategies

### Chapter 20 (Biomarker Research)
- 2-day CPET as robust functional biomarker
- Sensitivity/specificity for ME/CFS diagnosis
- Outcome measure for clinical trials

### Chapter 31 (Predictive Applications)
- Model PEM triggers using CPET parameters
- Recovery time predictions
- Personalized activity envelope calculations

## Key Quotes

> "Unlike controls, ME/CFS participants show impaired recovery following an exertional stressor."

> "Abnormal CPET responses cannot be explained by fitness alone and implicate disrupted cardiac, pulmonary, and metabolic factors related to autonomic nervous system dysregulation affecting oxygen delivery for energy metabolism."

> "ME/CFS failed to reproduce CPET-1 measures during CPET-2" (despite meeting maximal effort criteria)

## Future Research Directions Suggested

1. Longer recovery monitoring (beyond 24 hours) to determine full restoration time
2. Interventions targeting autonomic regulation
3. Biomarkers predicting severity of Day 2 impairment
4. Mechanisms linking central catecholamine dysfunction (Walitt) to peripheral exercise failure (Keller)

## Comparison to Historical Literature

This study is the **largest rigorous 2-day CPET study to date** (n=84 ME/CFS), building on:
- Stevens et al. (2018) - Methodology development
- Van Ness et al. (2010) - Initial demonstration of phenomenon
- Snell et al. (2013) - Diagnostic sensitivity findings

Keller 2024 provides definitive validation with robust statistical power and matched pair analysis.
